Loteprednol Etabonate

Alrex®, Lotemax®, Loteprednol, Loterox®

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

This profile has been selected from R&D Insight™, a pharmaceutical intelligence database produced by Adis International Ltd.

Novack GD, Howes J. Failure to detect systemic levels, and effects of loteprednol etabonate and its metabolite PJ-91 following chronic ocular administration. Clin Pharmacol Ther 59: 202, Feb 1996
Article Google Scholar
Friedlaender MH, Howes J. A double-masked, placebo-controlled evaluation of the efficacy and safety of loteprednol etabonate in the treatment of giant papillary conjunctivitis. Am J Ophthalmol 123: 455–464, Apr 1997
PubMed CAS Google Scholar
Dell SJ, Shulman DG, Lowry GM, et al. A controlled evaluation of the efficacy and safety of loteprednol etabonate in the prophylactic treatment of seasonal allergic conjunctivitis. Am J Ophthalmol 123: 791–797, Jun 1997
PubMed CAS Google Scholar
Bausch & Lomb Pharmaceuticals Inc. New data demonstrates value of Lotemax (Rm) ophthalmic steroid in treating postcataract surgery inflammation. Media Release: [2 pages], 20 Apr 1998
Google Scholar
Bartlett J, Horwitz B, Laibovitz R, et al. Intraocular pressure response to loteprednol etabonate in known steroid responders. J Ocul Pharmacol 9: 157–165, Summer 1993
Article PubMed CAS Google Scholar
Bartlett JD, Howes JF, Ghormley NR, et al. Safety and efficacy of loteprednol etabonate for treatment of papillae in contact lens-associated giant papillary conjunctivitis. Curr Eye Res 12: 313–321, Apr 1993
Article PubMed CAS Google Scholar

Loteprednol Etabonate. Drugs R&D 3, 154–157 (2002). https://doi.org/10.2165/00126839-200203030-00003

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.